Disposition Kinetics of Moclobemide, a New Mao‐A Inhibitor, in Subjects with Impaired Renal Function
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Pharmacokinetics
1982 • 3,815 citations
Estimation of Variance for Harmonic Mean Half-Lives
1985 • 304 citations
A Placebo-controlled Study of the Antidepressant Activity of Moclobemide,A New MAO-A Inhibitor
1984 • 61 citations
Determination of the new monoamine oxidase inhibitor moclobemide and three of its metabolites in biological fluids by high-performance liquid chromatography
1987 • 51 citations
Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: Single and multiple dosing in normal subjects
1987 • 50 citations
Moclobemide and clomipramine in the treatment of depression
1984 • 49 citations
A controlled study of a specific MAO a reversible inhibitor (R011-1163) and amitriptyline in depressive illness
1985 • 46 citations
Moclobemide, a new reversible MAO inhibitor ? interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients
1986 • 43 citations
Consequences of renal insufficiency on the hepatic clearance of some drugs.
1983 • 32 citations
Antidepressant Effect of Ro 11-1163, a New MAO Inhibitor
1982 • 31 citations
Single-dose pharmacokinetics of the MAO-inhibitor moclobemide in man.
1984 • 31 citations
A Simple Method for Obtaining the Mean Residence Time of Metabolites in the Body
1986 • 22 citations
Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites
1985 • 21 citations
Pharmacokinetics of tenoxicam in patients with impaired renal function
1986 • 20 citations
The lack of hepatotoxicity in the rat with the new and reversible MAO-A inhibitor moclobemide in contrast to iproniazid.
1985 • 19 citations